ANIK – Anika Therapeutics Inc.
Anika Therapeutics Inc.ANIK
$13.64Name : Anika Therapeutics Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $193,360,640.00
EPSttm : -0.6
Anika Therapeutics Inc.
$13.64
0.29%$0.04Float Short %
2.86
Margin Of Safety %
Put/Call OI Ratio
0.33
EPS Next Q Diff
0.22
EPS Last/This Y
0.15
EPS This/Next Y
0.09
Price
13.6
Target Price
24
Analyst Recom
1
Performance Q
-12.4
Relative Volume
0.62
Beta
0.77
Ticker: ANIK
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-12 | ANIK | 17.06 | 0.13 | 2.00 | 145 |
| 2025-03-13 | ANIK | 15.2 | 0.17 | 999.99 | 153 |
| 2025-03-14 | ANIK | 15.96 | 0.17 | 999.99 | 153 |
| 2025-03-17 | ANIK | 16.15 | 0.15 | 1.00 | 150 |
| 2025-03-18 | ANIK | 15.82 | 0.15 | 999.99 | 152 |
| 2025-03-19 | ANIK | 15.95 | 0.15 | 999.99 | 152 |
| 2025-03-20 | ANIK | 15.64 | 0.15 | 999.99 | 152 |
| 2025-03-21 | ANIK | 15.42 | 0.15 | 0.00 | 152 |
| 2025-03-24 | ANIK | 15.47 | 0.42 | 0.00 | 44 |
| 2025-03-25 | ANIK | 15.46 | 0.32 | 999.99 | 54 |
| 2025-03-26 | ANIK | 15.15 | 0.34 | 0.00 | 55 |
| 2025-03-27 | ANIK | 15.47 | 0.31 | 999.99 | 59 |
| 2025-03-28 | ANIK | 15.11 | 0.31 | 999.99 | 59 |
| 2025-03-31 | ANIK | 15.03 | 0.31 | 999.99 | 59 |
| 2025-04-01 | ANIK | 15.03 | 0.31 | 999.99 | 59 |
| 2025-04-02 | ANIK | 15.04 | 0.31 | 999.99 | 59 |
| 2025-04-03 | ANIK | 14.69 | 0.31 | 999.99 | 59 |
| 2025-04-04 | ANIK | 14 | N/A | N/A | 0 |
| 2025-04-07 | ANIK | 13.93 | N/A | N/A | 0 |
| 2025-04-08 | ANIK | 13.11 | N/A | N/A | 0 |
| 2025-04-09 | ANIK | 13.94 | 0.33 | 0.00 | 60 |
| 2025-04-10 | ANIK | 13.64 | 0.33 | 0.00 | 60 |
| 2025-04-11 | ANIK | 13.65 | 0.33 | 0.00 | 60 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-12 | ANIK | 17.06 | 80.0 | - | 0.10 |
| 2025-03-13 | ANIK | 15.21 | 80.0 | - | 0.10 |
| 2025-03-14 | ANIK | 15.91 | 80.0 | - | 0.47 |
| 2025-03-17 | ANIK | 16.11 | 0.0 | - | 0.31 |
| 2025-03-18 | ANIK | 15.83 | 0.0 | - | 0.31 |
| 2025-03-19 | ANIK | 15.95 | 0.0 | - | 0.31 |
| 2025-03-20 | ANIK | 15.62 | 0.0 | - | 0.31 |
| 2025-03-21 | ANIK | 15.35 | 0.0 | - | 0.31 |
| 2025-03-24 | ANIK | 15.49 | 0.0 | - | 0.31 |
| 2025-03-25 | ANIK | 15.42 | 0.0 | - | 0.31 |
| 2025-03-26 | ANIK | 15.16 | 0.0 | - | 0.31 |
| 2025-03-27 | ANIK | 15.46 | 0.0 | - | 0.31 |
| 2025-03-28 | ANIK | 15.11 | 0.0 | - | 0.31 |
| 2025-03-31 | ANIK | 15.03 | 0.0 | - | 0.31 |
| 2025-04-01 | ANIK | 15.03 | 0.0 | - | 0.31 |
| 2025-04-02 | ANIK | 15.05 | 0.0 | - | 0.31 |
| 2025-04-03 | ANIK | 14.68 | 0.0 | - | 0.31 |
| 2025-04-04 | ANIK | 14.05 | 0.0 | - | 0.31 |
| 2025-04-07 | ANIK | 13.92 | 0.0 | - | 0.31 |
| 2025-04-08 | ANIK | 13.14 | 0.0 | - | 0.31 |
| 2025-04-09 | ANIK | 13.95 | 0.0 | - | 0.31 |
| 2025-04-10 | ANIK | 13.64 | 0.0 | - | 0.31 |
| 2025-04-11 | ANIK | 13.60 | 0.0 | - | 0.31 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-12 | ANIK | 0.00 | -5.10 | 2.64 |
| 2025-03-13 | ANIK | 0.00 | -5.10 | 2.64 |
| 2025-03-14 | ANIK | 0.00 | -5.10 | 2.64 |
| 2025-03-17 | ANIK | 0.00 | -4.77 | 2.64 |
| 2025-03-18 | ANIK | 0.00 | -4.77 | 2.64 |
| 2025-03-19 | ANIK | 0.00 | -4.77 | 2.64 |
| 2025-03-20 | ANIK | 0.00 | -4.77 | 2.73 |
| 2025-03-21 | ANIK | 0.00 | -4.77 | 2.73 |
| 2025-03-24 | ANIK | 0.00 | -4.77 | 2.73 |
| 2025-03-25 | ANIK | 0.00 | -4.77 | 2.73 |
| 2025-03-26 | ANIK | 0.00 | -4.77 | 2.87 |
| 2025-03-27 | ANIK | 0.00 | -4.77 | 2.87 |
| 2025-03-28 | ANIK | 0.00 | -4.77 | 2.87 |
| 2025-03-31 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-01 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-02 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-03 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-04 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-07 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-08 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-09 | ANIK | 0.00 | -4.88 | 2.87 |
| 2025-04-10 | ANIK | 0.00 | -4.88 | 2.86 |
| 2025-04-11 | ANIK | 0.00 | -4.88 | 2.86 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.14
Avg. EPS Est. Current Quarter
0.09
Avg. EPS Est. Next Quarter
0.08
Insider Transactions
Institutional Transactions
-4.88
Beta
0.77
Average Sales Estimate Current Quarter
27
Average Sales Estimate Next Quarter
28
Fair Value
Quality Score
36
Growth Score
39
Sentiment Score
29
Actual DrawDown %
71.9
Max Drawdown 5-Year %
-72.7
Target Price
24
P/E
Forward P/E
24.14
PEG
P/S
1.27
P/B
1.28
P/Free Cash Flow
EPS
-3.84
Average EPS Est. Cur. Y
0.31
EPS Next Y. (Est.)
0.4
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-37.14
Relative Volume
0.62
Return on Equity vs Sector %
-56.2
Return on Equity vs Industry %
-44.6
EPS 1 7Days Diff
-0.2
EPS 1 30Days Diff
-0.16
EBIT Estimation
Anika Therapeutics Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 288
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company's joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today
news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance
stock history ANIK – Anika Therapeutics Inc. invest stock market
stock prices ANIK premarket after hours
ticker ANIK fair value insiders trading